Detalhe da pesquisa
1.
Unraveling MCL biology to understand resistance and identify vulnerabilities.
Blood
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551811
2.
Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma.
Blood
; 2024 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657242
3.
Obinutuzumab versus Rituximab in transplant-eligible Mantle cell lymphoma patients.
Blood
; 2024 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669626
4.
Mutational landscape of gray zone lymphoma.
Blood
; 137(13): 1765-1776, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961552
5.
Characterization of DLBCL with a PMBL gene expression signature.
Blood
; 138(2): 136-148, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33684939
6.
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Haematologica
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031755
7.
Personalised therapy in follicular lymphoma - is the dial turning?
Hematol Oncol
; 2023 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37482955
8.
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.
Am J Hematol
; 98(4): 645-657, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606708
9.
Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling.
Nat Methods
; 16(10): 1007-1015, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31501550
10.
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma.
Blood
; 134(10): 802-813, 2019 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292115
11.
Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases.
Br J Haematol
; 189(2): 244-256, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030731
12.
Single Cell Phenotypic Profiling of 27 DLBCL Cases Reveals Marked Intertumoral and Intratumoral Heterogeneity.
Cytometry A
; 97(6): 620-629, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31637838
13.
Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA.
Ann Hematol
; 99(8): 1771-1778, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32601796
14.
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.
Haematologica
; 104(1): 138-146, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171024
15.
Positron emission tomography-computed tomography before autologous stem cell transplant in follicular lymphoma: coming too late?
Haematologica
; 108(3): 661-662, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35586968
16.
Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?
Hematol Oncol
; 36(2): 399-406, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28983943
17.
Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes.
Hematol Oncol
; 2018 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29722049
18.
Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders.
Genes Chromosomes Cancer
; 56(3): 221-230, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27750397
19.
Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma.
Haematologica
; 107(8): 1928-1932, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320922
20.
Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association.
Haematologica
; 102(1): 150-159, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27758822